Reviva Pharmaceuticals Holdings, Inc. Stock
Equities
RVPH
US76152G1004
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.06 USD | -0.97% | -8.11% | -40.58% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 86.27M |
---|---|---|---|---|---|
Net income 2024 * | -43M | Net income 2025 * | -43M | EV / Sales 2024 * | - |
Net cash position 2024 * | 39.9M | Net cash position 2025 * | 31.9M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.12
x | P/E ratio 2025 * |
-2.34
x | Employees | 15 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.23% |
1 day | -0.97% | ||
1 week | -8.11% | ||
Current month | -19.05% | ||
1 month | -2.55% | ||
3 months | -24.63% | ||
6 months | -19.90% | ||
Current year | -40.58% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 59 | 20-12-10 | |
Narayan Prabhu
DFI | Director of Finance/CFO | 53 | 20-12-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 69 | 20-12-13 | |
Les Funtleyder
BRD | Director/Board Member | 55 | 20-12-13 |
Founder | 59 | 20-12-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 3.06 | -0.97% | 77 792 |
24-04-22 | 3.09 | +2.32% | 111,561 |
24-04-19 | 3.02 | 0.00% | 139,500 |
24-04-18 | 3.02 | -5.63% | 126,072 |
24-04-17 | 3.2 | -3.90% | 98,296 |
Delayed Quote Nasdaq, April 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.58% | 86.27M | |
+3.13% | 42.11B | |
+48.83% | 40.08B | |
+8.49% | 40B | |
-10.82% | 26.87B | |
+8.26% | 24.58B | |
-23.69% | 18.44B | |
+1.58% | 11.94B | |
+32.83% | 11.66B | |
+6.63% | 11.01B |
- Stock Market
- Equities
- RVPH Stock